This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HIG Q2 Earnings Beat on Premium Growth in Business Insurance Unit
by Zacks Equity Research
Hartford's Q2 earnings benefit from strong premium gains and improved loss ratios in Business Insurance and Personal Insurance units, partly offset by higher benefit costs.
RNR Q2 Earnings Beat on Strong Property Underwriting Results
by Zacks Equity Research
RenaissanceRe's Q2 earnings benefit from strong Property underwriting results and lower net claims and claim expenses incurred, partly offset by declining net premiums earned in the Casualty & Specialty unit.
RenaissanceRe (RNR) Tops Q2 Earnings Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of +19.55% and -4.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for RenaissanceRe (RNR) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of RenaissanceRe (RNR) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
W.R. Berkley Gears Up to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
WRB's second-quarter results are likely to reflect higher premiums, coupled with improved investment income, partially offset by escalating expenses.
RenaissanceRe (RNR) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
RenaissanceRe (RNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in Store for Progressive This Earnings Season?
by Zacks Equity Research
PGR eyes a 62.3% earnings jump and 17.9% revenue growth in Q2, with solid premiums and investment gains driving momentum.
Is a Beat in the Cards for Travelers This Earnings Season?
by Zacks Equity Research
TRV's Q2 results are likely to reflect solid renewal rate change, strong retention in high-quality Management Liability business and higher long-term average yields.
FAF Stock Trading at a Discount to Industry at 1.18X: Time to Hold?
by Zacks Equity Research
First American is set to gain from investments in technology, expanding valuation and data businesses and effective capital deployment.
Hanover Insurance Stock Near 52-Week High: Time to Buy?
by Zacks Equity Research
THG nears its 52-week high as strong segment performance, tech upgrades, and bullish trends drive investor interest.
Why Is Allstate (ALL) Up 4.8% Since Last Earnings Report?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Cincinnati Financial (CINF) Up 6.9% Since Last Earnings Report?
by Zacks Equity Research
Cincinnati Financial (CINF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe (RNR) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
First American Trades at a Discount: How to Play the Stock
by Zacks Equity Research
FAF stock is set to gain from investments in technology, expanding valuation and data businesses and effective capital deployment.
NMI Holdings Trades Above 50-Day SMA: Time to Hold NMIH Stock?
by Zacks Equity Research
NMIH is well-positioned for growth, with higher new insurance written volume, a comprehensive reinsurance program and prudent capital deployment.
RenaissanceRe Q1 Earnings Miss on High Expenses & California Wildfires
by Zacks Equity Research
RNR continues to witness growth in net premiums earned from the property segment.
RenaissanceRe (RNR) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for RenaissanceRe (RNR) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
RenaissanceRe (RNR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of -365.63% and 7.79%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
RenaissanceRe (RNR) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for RenaissanceRe (RNR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Earnings Preview: RenaissanceRe (RNR) Q1 Earnings Expected to Decline
by Zacks Equity Research
RenaissanceRe (RNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RenaissanceRe Expands Cat Bond Business With $340M Medici UCITS Fund
by Zacks Equity Research
This new fund aligns with RNR's broader strategy of expanding globally, diversifying capital sources and strengthening its investment platform.
RenaissanceRe (RNR) Down 2.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe Q4 Earnings Beat on Premium Growth in Property Unit
by Zacks Equity Research
RNR's Q4 results benefit from account renewals as a result of the Validus buyout and higher yields from the fixed maturity portfolio, partly offset by an increase in claim expenses.
Compared to Estimates, RenaissanceRe (RNR) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for RenaissanceRe (RNR) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
RenaissanceRe (RNR) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 5.91% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?